none4noThe ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is described from a scientific point of view. This case study illustrates some of the strategies adopted by generic bulk manufacturers to challenge originator's patents on polymorphic forms.mixedCabri W; Ghetti P; Pozzi G; Alpegiani MCabri W; Ghetti P; Pozzi G; Alpegiani
The pharmaceutical market is a billon euro industry and the competition on the market is highly inte...
Herpin Paulette. Polymorphism and polytypism in crystals, par A. R. Verma et P. Krishna, 1966. In: B...
Abstract. This article is the text of the lecture presented for the XXVlI JEEP in Montpellier. Polym...
none4noThe ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is describe...
none4noThe ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is describe...
polimorhisms represent one of the most critical and controversial area of drug patent
polimorhisms represent one of the most critical and controversial area of drug patent
Called pharmaceutical polymorphism to change of the crystal structure of a substance when it is in i...
Polymorphism is the ability of a specific chemical compound to crystallize in more than one crystall...
ABSTRACT − Polymorphism has been recognized to be a critical issue throughout the drug product devel...
Formulators are charged with the responsibility of formulating a product which is physically and che...
Prevalence and importance of polymorphism occurring in pharmaceutical compounds are well recognized....
ABSTRACT: Litigation plague does become a major worry for investors, assignees, inventors and relate...
The pharmaceutical market is a billon euro industry and the competition on the market is highly inte...
Polymorphism in the evolution of quality control of drugs is discussed and the possible relationship...
The pharmaceutical market is a billon euro industry and the competition on the market is highly inte...
Herpin Paulette. Polymorphism and polytypism in crystals, par A. R. Verma et P. Krishna, 1966. In: B...
Abstract. This article is the text of the lecture presented for the XXVlI JEEP in Montpellier. Polym...
none4noThe ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is describe...
none4noThe ongoing patent battle relating to Cefdinir polymorphism and crystalline forms is describe...
polimorhisms represent one of the most critical and controversial area of drug patent
polimorhisms represent one of the most critical and controversial area of drug patent
Called pharmaceutical polymorphism to change of the crystal structure of a substance when it is in i...
Polymorphism is the ability of a specific chemical compound to crystallize in more than one crystall...
ABSTRACT − Polymorphism has been recognized to be a critical issue throughout the drug product devel...
Formulators are charged with the responsibility of formulating a product which is physically and che...
Prevalence and importance of polymorphism occurring in pharmaceutical compounds are well recognized....
ABSTRACT: Litigation plague does become a major worry for investors, assignees, inventors and relate...
The pharmaceutical market is a billon euro industry and the competition on the market is highly inte...
Polymorphism in the evolution of quality control of drugs is discussed and the possible relationship...
The pharmaceutical market is a billon euro industry and the competition on the market is highly inte...
Herpin Paulette. Polymorphism and polytypism in crystals, par A. R. Verma et P. Krishna, 1966. In: B...
Abstract. This article is the text of the lecture presented for the XXVlI JEEP in Montpellier. Polym...
DOI
Add to ORKG